Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
The NHS has released an online tool to help patients check if they are eligible for certain weight loss medications - use the ...
The FDA rejected sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...
A previous crop of weight-loss drugs, like Qsymia, a combination of older medicines not part of the GLP-1 class, and liraglutide, an earlier GLP-1 medicine sold under the brand name Saxenda ...
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...
"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly ...